The PBM encourages step-therapy to control costs.
The patient population is small, at around 3,000, but the expected price tag is $330,000 a year.
The catch is the difference between sales and revenues. Generics will continue to be a force, and small-audience drugs will become increasingly important.
Dudnyk bought San Francisco-based Stratagem, expanding its West Coast presence and adding medical-device marketing expertise, the agency said.
The promotion of Ane Jones to president is the latest management change at the Omnicom specialty agency and its bigger sibling, Harrison & Star.
Specialty biopharma firms are using razor-sharp therapeutic focus to target "niche buster" categories.